Skip to main content Help with accessibility Skip to main navigation

All Guidance

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - November - 2018
BNF chapter: Endocrine system

For hypogonadism due to testosterone deficiency in adult men

Indication (licensed):Testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

 

Pending
Adopted
Pending
Pending
Adopted
Pending
Adopted
Pending
Date Posted: 15 - August - 2022
BNF chapter: Endocrine system

Unlicensed indication: As supplementation for postmenopausal women with low sexual desire if HRT alone is not effective.

***Please note: the shared care guideline for the use of testosterone by postmenopausal women with low sexual desire has been clinically approved by LSCMMG. In the absence of a commissioned service, it is for individual prescribers to assess their own competence to work to the shared care, that appropriate specialist initiation has occurred and that appropriate risk assessments have been undertaken. Please contact mlcsu.medicinesmanagement@nhs.net for further information***

Further patient information is available via the RCOG menopause hub:
https://www.rcog.org.uk/for-the-public/menopause-and-later-life/
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - July - 2019
BNF chapter: Endocrine system

Prescribing Information Sheet: To be read in conjunction with the relevant SPCs

Please note: NHSE has stated that GICs should retain responsibility for providing prescriptions and for monitoring until the GP has agreed to a transfer of responsibilities. Individual prescribers MUST only prescribe within their own level of competence

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - July - 2019
BNF chapter: Endocrine system

Prescribing Information Sheet: To be read in conjunction with the relevant SPCs

Please note: NHSE has stated that GICs should retain responsibility for providing prescriptions and for monitoring until the GP has agreed to a transfer of responsibilities. Individual prescribers MUST only prescribe within their own level of competence

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - April - 2016

Trans-anal Irrigation Systems are recommended for use within the Lancashire Health Economy for the treatment of Neurogenic Bowel Dysfunction and Non-Neurogenic Bowel Dysfunction including; chronic constipation and chronic faecal incontinence

**This Guideline is currently under review. For further information please click here**

 

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Pending
Date Posted: 18 - October - 2022

This leaflet explains how some medicines are used differently to how they were originally developed and approved.

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Pending
Date Posted: 01 - July - 2015
BNF chapter: Blood and Nutrition
**This Guideline is currently under review. For further information please click here**
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - September - 2017
BNF chapter: Blood and Nutrition

This position statement covers all single-ingredient preparations of vitamin D prescribed within the Lancashire NHS health economy for the management of deficiency and insufficiency states. This document is not intended to provide full guidance for the use of vitamin D within the NHS in Lancashire. Local protocols should also be consulted where they exist.

For additional prescribing information see Vitamin D Prescriber Resources in our Clinical Resources section

Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Adopted
Date Posted: 01 - October - 2016
BNF chapter: Blood and Nutrition

This policy only covers preparations without a product licence. Preparations with a product licence should only be prescribed for its licensed indications.

The prescribing of Vitamins, Minerals, Supplements, Herbal and Homeopathic medicines without a product licence in the NHS in primary care and secondary care in Lancashire is not recommended unless funding has been agreed for an individual product for a specific indication.

**This Guideline is currently under review. For further information please click here**